In Europe in particular “consumer sentiment is deteriorating,” CFO Graeme Pitkethly said during the firm’s 27 October third-quarter earnings call. Unilever has more pricing actions planned but recognizes that consumers are having to make trade-offs due to inflation and private label is gaining share in some product categories.
Unilever PLC saw only a small decline in sales volume in the third quarter after increasing pricing across its portfolio by 12.5%, reportedly its highest level yet, but the firm warned recession concerns are growing and inflation is prompting a pullback in consumer spending in the US and Europe.
The British company reported underlying sales growth of 10.6% to €15.8bn ($15.74bn) in the third quarter, with pricing accounting largely...
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
CEO Sue Nabi says Coty has created a “multi-functional, stand-alone organization” within its Consumer Beauty business to drive rapid-fire innovation. In a 20 August presentation, Nabi said the firm’s innovation pipeline undergirds its fiscal 2025 outlook of 6%-8% growth.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
